Free tool
FAERS Monitor: Xenazine
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021894 or its brand name (Xenazine, Tetrabenazine). Reports on generic versions are filed under their own applications.
Reports
7,327
Serious
4,082
56% of reports
Hospitalization
1,509
Death reported
1,533
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- death1,222
- off label use1,138
- drug ineffective708
- depression476
- somnolence451
- fatigue361
- fall318
- hospitalisation301
- insomnia276
- intentional product use issue274
- anxiety263
- drug administration error241
- condition aggravated234
- drug dose omission224
- dyskinesia224
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 8 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 187 |
| 2010 | 450 |
| 2011 | 279 |
| 2012 | 319 |
| 2013 | 353 |
| 2014 | 1,453 |
| 2015 | 1,833 |
| 2016 | 560 |
| 2017 | 699 |
| 2018 | 201 |
| 2019 | 139 |
| 2020 | 145 |
| 2021 | 162 |
| 2022 | 124 |
| 2023 | 97 |
| 2024 | 119 |
| 2025 | 91 |
| 2026 | 91 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,832 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug administration errorSignal | 241 | 22.7 | 20.1 | 4,949 |
| dyskinesiaSignal | 224 | 15.9 | 14.0 | 3,103 |
| intentional product use issueSignal | 274 | 9.0 | 8.0 | 1,943 |
| somnolenceSignal | 451 | 6.4 | 5.9 | 2,083 |
| depressionSignal | 476 | 6.0 | 5.5 | 2,003 |
| hospitalisationSignal | 301 | 5.6 | 5.0 | 1,148 |
| deathSignal | 1,222 | 4.1 | 3.9 | 2,951 |
| drug dose omissionSignal | 224 | 3.9 | 3.4 | 482 |
| off label useSignal | 1,138 | 3.7 | 3.5 | 2,371 |
| insomniaSignal | 276 | 3.0 | 2.7 | 365 |
| fallSignal | 318 | 2.7 | 2.5 | 356 |
| anxietySignal | 263 | 2.7 | 2.4 | 273 |
| condition aggravatedSignal | 234 | 2.2 | 1.9 | 156 |
| drug ineffective | 708 | 1.5 | 1.4 | 143 |
| fatigue | 361 | 1.3 | 1.2 | 31 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.